Lengthening of Q-Tinterval in isoniazid treatment (case report and review of literature)


Cite item

Full Text

References

  1. Dessertene F. La tachycardie ventriculaire a deux foyers opposes variables. Arch. Mai. Coeur 1966; 59: 263-272.
  2. Locati E. Torsades de pointes. In: Moss A., Stern S. eds. Noninvasive electrocardiology. Clinical aspects of Holter monitor ing. Saunders Co; University Press, Cambridge, UK; 1997. 59-73.
  3. Selzer A., Wray H. Quinidine syncope. Paroxysmal ventricular fibrillation occuring during treatment of chronic atrial arrhythmias. Circulation 1964; 30: 17-26.
  4. Макаров Л. М. Холтеровское мониторирование. М.: Медпрактика; 2000.
  5. Jervell A., Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with prolongation of Q- T interval and sudden death. Am. Heart J. 1957; 54: 59-68.
  6. Romano C, Gemme G, Pongiglione R. Aritmie cardiache rare dell' eta pediatrica. II. Accessi sincopali per fibrillazione ventricolare parossistica. (Presentazione del primo caso della letteratura pediatrica Italiana.). Clin. Pediatr. 1963; 45: 656-683.
  7. Ward О. С A new familial cardiac syndrome in children. J. Irish Med. Assoc. 1964; 54: 103-106.
  8. Pagano L., Delia Monica R., Malinconico M. Proarrhythmia due to the amiodarone. Minerva Cardioangiol. 2001; 49 (6): 421-428.
  9. Glassman A. #., Bigger J. T. Jr. Antipsychotic drugs: Prolonged QTc interval, torsade de pointes, and sudden death. Am. J. Psychiatry 2001; 158 (11): 1774-1782.
  10. Meuleman C., Jourdain P., Bellorini M. et al. Citalopram and Torsades de Pointes. A case report. Arch. Mai. Coeur 2001; 94 (9): 1021-1024.
  11. Roden D. M. Pharmacogenetics and drug-induced arrhythmias. Cardiovasc, Res. 2001; 50 (20): 224-231.
  12. Drici M. D., Clement N. Is gender a risk factor adverse drug reactions? The example of drug-induced long QT syndrome. Drug Saf. 2001; 24 (80): 575-585.
  13. Diaz-Peromingo J. A., Marino-Callejo A. I., Gonzalez-Gonzalez С et al. Tuberculous myocarditis presenting as long QT syndrome. Eur. J. Int. Med. 2000; 11 (6): 340-342.
  14. Chan A. C, Dickens P. Tuberculous myocarditis presenting as sudden cardiac death. Forens. Sci. Int. 1992; 57 (1): 45-50.
  15. Hassan D. N., Hanna A. J. Tuberculosis and sudden death in Baghdad. Am. J. Forens. Med. Pathol. 1984; 5 (2): 169-174.
  16. Chapman R. C, Claydon S. M. Mycobacterium tuberculosis: a continuing cause of sudden and unexpected death in west Lon-don. J. Clin. Pathol. 1992; 45 (8): 713-715.
  17. Alkhuja S., Miller A. Tuberculosis and sudde death: a case report and review. Heart and Lung 2001; 30 (5): 388-391.
  18. Справочник Видаль. Лекарственные препараты в России: Справочник. М.: АстраФармСервис; 1999.
  19. Roy M., Dumaine R., Brown A. HERG a primary human ventricylar target of the nonsedating antihitamine terfanadine. Circulation 1996; 94: 817-823.
  20. Mitcheson J., Chen J., Lin M. et al. A structural basis for druginduced long QT syndrome. Proc. Natl. Acad. Sci. USA. 2000; 97 (22): 12329-12333.
  21. Sesti F.. Abbott G., Wei J. et al. A common polymorphism as sociated with antibiotic-induced cardiac arrhythmia. Ibid. (19): 10613-10618.
  22. Лоуренс Д., Беннит П. Клиническая фармакология: Пер. англ. М.: Медицина; 1993; т. 1.
  23. Лильин Е. Т., Трубников В. И., Ванюков М. М. Введение в современную фармакогенетику. М.: Медицина; 1984.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2003 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies